跳至主要内容
临床试验/IRCT2012123010279N2
IRCT2012123010279N2已完成3 期

Comparison of the efficiency of Saccharomyces boulardii on neonatal hyperbilirubinemia with placebo on late pereterm and term neonates

Health Ministry Drug and Pharmacy General Management0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 1 year(—)
性别
All

入选标准

  • 1.Late preterm (34, not completed week – 36, completed week) gestational weeks ) and term (= 37 gestational weeks) neonates
  • 2. Newborns who need phototherapy for neonatal hyperbilirubinemia
  • 3. Newborns who were 0-1 month old.
  • Exclusion criteria:
  • 1. Newborns who have congenital anomalies
  • 2. Newborns who need intense phototherapy
  • 3.Direct coombs positive ABO/Rh incompatability
  • 4.Neonates who have sepsis/pneumonia during phototherapy
  • 5.Neonates with hypothyroidism
  • 6.Neonates who have gastrointestinal obstruction
  • 7.Neonates with asphyxia
  • 8.Contraindication of peroral feeding

排除标准

  • 未提供

研究者

发起方
Health Ministry Drug and Pharmacy General Management

相似试验